Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extensive cutaneous plasmacytomas

R Carere1, A K Stewart, D Bailey

  • 1Department of Medicine, Toronto Hospital, Ontario, Canada.

Leukemia & Lymphoma
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of low-mode symmetry on inertial fusion energy output in the burning plasma state.

Nature communications·2024
Same author

An occupational health survey of the UK's mortuary workforce.

Occupational medicine (Oxford, England)·2023
Same author

Plasma Exchange for Acute Renal Failure of Myeloma-Logical, Yet Ineffective: Plasma Exchange When Myeloma Presents as Acute Renal Failure. A Randomized, Controlled Trial. Ann Int Medicine 143: 777-784, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Metagenomic shotgun sequencing of blood to identify bacteria and viruses in leukemic febrile neutropenia.

PloS one·2022
Same author

Evaluation of electropolymerized molecularly imprinted polymers (E-MIPs) on disposable electrodes for detection of SARS-CoV-2 in saliva.

Analytica chimica acta·2022
Same author

The Stickland Reaction Precursor <i>trans</i>-4-Hydroxy-l-Proline Differentially Impacts the Metabolism of Clostridioides difficile and Commensal <i>Clostridia</i>.

mSphere·2022
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026
Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
Same journal

Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

Leukemia & lymphoma·2026
See all related articles

This case report details extensive skin and breast plasmacytomas, a rare manifestation of plasma cell myeloma. It reviews literature on this unusual presentation of multiple myeloma.

Area of Science:

  • Oncology
  • Dermatology
  • Pathology

Background:

  • Multiple myeloma is a plasma cell malignancy typically affecting bone marrow.
  • Extramedullary plasmacytomas can occur but extensive cutaneous and subcutaneous involvement is rare.

Observation:

  • A case of extensive cutaneous and subcutaneous plasmacytomas is presented.
  • Breast involvement was a notable feature in this patient.
  • This presentation is considered an unusual manifestation of plasma cell myeloma.

Findings:

  • The case highlights the potential for widespread skin and soft tissue infiltration by plasma cell tumors.
  • Review of literature reveals limited data on such extensive extramedullary disease.

Implications:

Related Experiment Videos

  • This case expands the understanding of plasmacytoma presentation.
  • It underscores the importance of considering extramedullary disease in myeloma diagnosis.
  • Further research into the behavior and management of extensive plasmacytomas is warranted.